Trinity Biotech plc (TRIB) Balance Sheet
TRIB balance sheet, 2025
December 31, 2025 · U.S. dollars$105.2M assets = $177.1M liabilities + −$72.0M equity
Liabilities exceed assets: shareholders’ equity is negative (−$72.0M).
Both columns are drawn to the same scale: what TRIB owns equals what it owes plus shareholders’ equity. Hover a block for its value.
TRIB financial health
Descriptive bands, not a rating. Fiscal 2025.
TRIB balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $249.6M2016 | $105.2M2025 | −9.2%/yr | |
| Total liabilities | $140.9M2016 | $177.1M2025 | +2.6%/yr | |
| Shareholders’ equity | $108.7M2016 | −$72.0M2025 | — | |
| Cash & short-term investments | $77.1M2016 | $5.1M2025 | −26.0%/yr | |
| Total debt | $96.8M2016 | $138.0M2025 | +4.0%/yr | |
| Net cash (debt) | −$19.7M2016 | −$132.8M2025 | −$113.2M | |
| Working capital | $108.2M2016 | −$105.3M2025 | −$213.5M | |
| Book value per share | −$1.802021 | −$116.252025 | — | |
| Current ratio | 5.282016 | 0.252025 | −5.03 | |
| Debt / equity | 0.892016 | 21.682019 | +20.79 | |
| Shares outstanding | 178K2021 | 619K2025 | +36.7%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
TRIB assets
TRIB liabilities and equity
TRIB debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
TRIB balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $5.1M | $5.2M | $3.7M | $6.6M | $25.9M | $27.3M | $16.4M | $30.3M | $57.6M | $77.1M |
| Cash & equivalents | $5.1M | $5.2M | $3.7M | $6.6M | $25.9M | $27.3M | $16.4M | $30.3M | $57.6M | $77.1M |
| Short-term investments | — | — | — | — | — | $0 | $1.2M | $23.4M | $34.0M | — |
| Receivables | $10.3M | $14.6M | $13.4M | $15.7M | $15.7M | $24.6M | $23.0M | $26.0M | $22.2M | $23.8M |
| Inventory | $18.8M | $19.4M | $19.9M | $22.5M | $29.1M | $30.2M | $32.0M | $30.4M | $32.8M | $32.6M |
| Other current assets | $1.7M | $2.0M | $2.0M | $1.9M | $1.9M | $1.2M | $0 | $0 | $0 | $0 |
| Total current assets | $35.9M | $41.1M | $39.0M | $46.7M | $72.7M | $83.3M | $71.4M | $86.7M | $112.6M | $133.5M |
| Property, plant & equipment (net) | $5.3M | $4.6M | $1.9M | $5.7M | $5.9M | $8.5M | $9.3M | $5.4M | $5.8M | $13.4M |
| Goodwill & intangible assets | $57.0M | $51.3M | $16.3M | $35.3M | $36.0M | $33.9M | $43.7M | $53.0M | $64.8M | $87.3M |
| Long-term investments | $2.8M | $2.5M | $0 | $0 | $0 | $0 | $0 | $0 | $360,000 | $0 |
| Other non-current assets | $4.2M | $3.7M | $2.2M | $4.5M | $4.3M | $4.7M | $6.7M | $6.3M | $9.1M | $15.4M |
| Total assets | $105.2M | $103.3M | $59.4M | $92.1M | $118.9M | $130.4M | $131.1M | $151.2M | $192.6M | $249.6M |
| Liabilities | ||||||||||
| Accounts payable | $11.5M | $6.8M | $3.9M | $6.2M | $6.8M | $7.1M | $19.4M | $17.3M | $20.8M | $25.0M |
| Short-term debt | $110.8M | $2.5M | $1.9M | $1.9M | $85.3M | $5.1M | $2.4M | $436,000 | $354,000 | $273,000 |
| Deferred revenue | $187,000 | $197,000 | $50,000 | $114,000 | $141,000 | $4.4M | $292,000 | $312,000 | $278,000 | $224,000 |
| Total current liabilities | $141.2M | $32.1M | $15.0M | $17.3M | $100.5M | $27.1M | $19.4M | $17.6M | $21.2M | $25.3M |
| Long-term debt | $16.3M | $87.8M | $54.7M | $58.0M | $0 | $83.9M | $99.8M | $81.6M | $94.8M | $96.5M |
| Lease obligations | $13.4M | $12.8M | $12.6M | $13.9M | $15.8M | $18.7M | $20.1M | $962,000 | $886,000 | $1.0M |
| Other long-term liabilities | $19.6M | $18.6M | $13.7M | $18.9M | $18.7M | $21.7M | $7.1M | $8.0M | $11.4M | $19.1M |
| Total liabilities | $177.1M | $138.5M | $83.4M | $94.3M | $119.2M | $132.6M | $126.4M | $107.2M | $127.4M | $140.9M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $40,000 | $4.2M | $2.0M | $2.0M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M |
| Retained earnings (deficit) | −$116.2M | −$79.1M | −$48.6M | −$26.7M | $12.6M | $10.6M | $11.5M | $24.4M | $46.2M | $93.0M |
| Treasury stock | — | — | — | — | — | — | −$24.9M | −$28.7M | −$24.8M | −$17.3M |
| Accumulated other comprehensive income | $5.3M | −$5.4M | $1.0M | −$5.7M | −$5.4M | −$5.3M | −$24.2M | $2.3M | $1.6M | −$1.7M |
| Total shareholders' equity | −$72.0M | −$35.2M | −$23.9M | −$2.2M | −$319,000 | −$2.2M | $4.7M | $44.1M | $65.2M | $108.7M |
| Key figures | ||||||||||
| Total debt | $138.0M | $100.8M | $67.4M | $72.2M | $99.2M | $104.3M | $102.2M | $82.1M | $95.2M | $96.8M |
| Net cash (debt) | −$132.8M | −$95.6M | −$63.7M | −$65.6M | −$73.2M | −$77.0M | −$85.8M | −$51.8M | −$37.6M | −$19.7M |
| Working capital | −$105.3M | $9.0M | $24.0M | $29.3M | −$27.8M | $56.2M | $51.9M | $69.1M | $91.4M | $108.2M |
| Tangible book value | −$129.0M | −$86.5M | −$40.2M | −$37.4M | −$36.3M | −$36.1M | −$38.9M | −$8.9M | $442,000 | $21.5M |
| Book value per share | −$116.25 | −$58.77 | −$93.86 | −$8.40 | −$1.80 | — | — | — | — | — |
| Shares outstanding | 619K | 599K | 255K | 259K | 178K | — | — | — | — | — |
| Current ratio | 0.25 | 1.28 | 2.60 | 2.69 | 0.72 | 3.08 | 3.67 | 4.92 | 5.30 | 5.28 |
| Quick ratio | 0.11 | 0.62 | 1.14 | 1.28 | 0.41 | 1.92 | 2.02 | 3.20 | 3.76 | 3.99 |
| Debt / equity | — | — | — | — | — | — | 21.68 | 1.86 | 1.46 | 0.89 |
| Equity / assets | −68.4% | −34.1% | −40.3% | −2.4% | −0.3% | −1.7% | 3.6% | 29.1% | 33.8% | 43.6% |
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $5.1M | $5.1M | $1.3M | $1.5M | $4.1M | $5.2M | $2.8M | $5.3M | $5.8M | $5.8M | $6.3M | $14.2M |
| Cash & equivalents | $5.1M | $5.1M | $1.3M | $1.5M | $4.1M | $5.2M | $2.8M | $5.3M | $5.8M | $5.8M | −$12.5M | −$13.2M |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | $18.8M | $27.4M |
| Receivables | $10.3M | $9.4M | $15.0M | $10.9M | $11.2M | $14.6M | $21.4M | $17.5M | $17.6M | $17.6M | $16.7M | $16.1M |
| Inventory | $18.8M | $18.8M | $19.2M | $20.1M | $20.3M | $19.4M | $21.8M | $23.0M | $22.6M | $22.6M | $20.9M | $22.6M |
| Other current assets | $1.7M | $2.6M | $0 | $431,000 | $0 | $2.0M | $0 | $240,000 | $0 | $0 | $0 | $0 |
| Total current assets | $35.9M | $35.9M | $35.5M | $33.0M | $35.5M | $41.1M | $46.1M | $46.0M | $46.0M | $46.0M | $43.8M | $52.9M |
| Property, plant & equipment (net) | $5.3M | $5.3M | $4.0M | $4.3M | $4.4M | $4.6M | $3.8M | $3.9M | $3.4M | $3.4M | $1.8M | $1.9M |
| Goodwill & intangible assets | $57.0M | $57.0M | $57.8M | $55.9M | $53.7M | $51.3M | $46.7M | $41.8M | $38.6M | $38.6M | $16.2M | $15.8M |
| Long-term investments | $0 | $2.8M | $0 | $2.8M | $0 | $2.5M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $7.0M | $4.2M | $6.4M | $3.6M | $6.2M | $3.7M | $927,000 | $2.7M | $2.3M | $2.3M | $1.8M | $1.4M |
| Total assets | $105.2M | $105.2M | $103.7M | $99.6M | $99.8M | $103.3M | $97.4M | $94.4M | $90.3M | $90.3M | $63.6M | $72.0M |
| Liabilities | ||||||||||||
| Accounts payable | $29.7M | $11.5M | $30.4M | $26.5M | $25.3M | $6.8M | $25.3M | $23.1M | $20.5M | $20.5M | $10.6M | $12.6M |
| Short-term debt | $110.8M | — | $2.3M | — | $2.4M | $2.5M | $2.4M | — | $1.9M | $1.9M | $1.8M | $1.9M |
| Deferred revenue | — | — | — | — | — | $197,000 | $283,000 | — | $337,000 | $337,000 | — | — |
| Total current liabilities | $141.2M | $141.2M | $34.5M | $31.5M | $30.5M | $32.1M | $28.1M | $25.8M | $22.8M | $22.8M | $12.7M | $14.8M |
| Long-term debt | $0 | $16.3M | $0 | $99.5M | $0 | $87.8M | $81.6M | $80.8M | $73.4M | $54.7M | $54.3M | $53.9M |
| Lease obligations | — | $13.4M | — | $12.8M | — | $12.8M | $11.9M | $12.4M | $12.0M | $12.6M | $12.5M | $13.2M |
| Other long-term liabilities | $35.9M | $19.6M | $123.9M | $18.1M | $112.9M | $18.6M | $14.1M | $17.2M | $16.9M | $35.7M | $14.1M | $14.7M |
| Total liabilities | $177.1M | $177.1M | $158.4M | $149.2M | $143.4M | $138.5M | $123.8M | $123.8M | $113.2M | $113.2M | $81.1M | $83.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $40,000 | — | $39,999 | — | $4.3M | $4.2M | $2.4M | — | $2.3M | $2.3M | $2.0M | $2.0M |
| Retained earnings (deficit) | −$116.2M | −$116.2M | −$98.7M | −$93.7M | −$87.8M | −$79.1M | −$62.3M | −$57.8M | −$51.1M | −$51.1M | −$42.1M | −$36.2M |
| Accumulated other comprehensive income | $5.3M | — | $5.0M | — | $946,000 | −$5.4M | −$5.7M | — | $928,000 | $928,000 | −$5.7M | −$5.6M |
| Total shareholders' equity | −$72.0M | −$72.0M | −$54.7M | −$49.5M | −$43.6M | −$35.2M | −$26.3M | −$29.4M | −$22.9M | −$22.9M | −$17.5M | −$11.4M |
| Key figures | ||||||||||||
| Total debt | $138.0M | $16.3M | $117.2M | $99.5M | $108.0M | $100.8M | $93.7M | $80.8M | $85.6M | $85.6M | $67.0M | $67.3M |
| Net cash (debt) | −$132.8M | −$11.2M | −$115.9M | −$98.0M | −$103.9M | −$95.6M | −$90.9M | −$75.5M | −$79.9M | −$79.9M | −$60.8M | −$53.1M |
| Working capital | −$105.3M | −$105.3M | $1.0M | $1.5M | $5.1M | $9.0M | $18.0M | $20.2M | $23.2M | $23.2M | $31.1M | $38.2M |
| Tangible book value | −$129.0M | −$129.0M | −$112.5M | −$105.5M | −$97.3M | −$86.5M | −$73.0M | −$71.2M | −$61.4M | −$61.4M | −$33.7M | −$27.1M |
| Book value per share | −$115.93 | — | −$87.99 | — | −$71.52 | −$74.47 | −$76.08 | — | −$77.28 | — | −$68.44 | −$44.59 |
| Shares outstanding | 621K | — | 622K | — | 610K | 472K | 346K | — | 296K | — | 256K | 255K |
| Current ratio | 0.25 | 0.25 | 1.03 | 1.05 | 1.17 | 1.28 | 1.64 | 1.78 | 2.02 | 2.02 | 3.44 | 3.59 |
| Quick ratio | 0.11 | 0.10 | 0.47 | 0.39 | 0.50 | 0.62 | 0.87 | 0.88 | 1.03 | 1.03 | 1.80 | 2.06 |
| Equity / assets | −68.4% | −68.4% | −52.8% | −49.7% | −43.7% | −34.1% | −27.0% | −31.2% | −25.3% | −25.3% | −27.5% | −15.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 30, 2026); data from EODHD.
TRIB financial position
At the end of fiscal 2025 (December 31, 2025), Trinity Biotech had total assets of $105.2 million (up 1.8% from a year earlier), total liabilities of $177.1 million and shareholders' equity of -$72.0 million. It held $5.1 million in cash and short-term investments against $138.0 million of debt, net debt of $132.8 million. Its current ratio was 0.25. In the latest quarter (ended March 31, 2026) total assets were $105.2 million and equity -$72.0 million.
Related: TRIB income statement, TRIB cash flow statement, TRIB key metrics. See the TRIB stock overview for the latest quote and news.
TRIB balance sheet FAQ
What are Trinity Biotech's total assets?
Trinity Biotech reported total assets of $105.2 million at the end of fiscal 2025 (December 31, 2025), compared with $103.3 million a year earlier.
How much debt does Trinity Biotech have?
Trinity Biotech had $138.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Trinity Biotech have?
Trinity Biotech held $5.1 million in cash and short-term investments at the end of fiscal 2025; with $138.0 million of debt that is net debt of $132.8 million.
What is Trinity Biotech's book value?
Trinity Biotech's shareholders' equity (book value) was -$72.0 million at the end of fiscal 2025, or −$116.25 per share.
What is Trinity Biotech's current ratio?
Trinity Biotech had current assets of $35.9 million and current liabilities of $141.2 million, a current ratio of 0.25 (current liabilities exceed current assets).
How much goodwill does Trinity Biotech have?
Trinity Biotech carried $57.0 million of goodwill and intangible assets, 54.2% of total assets, at the end of fiscal 2025.